New Developments in Reverse Payments: A crescendo or more of the same?
12 PM EDT
Pharmaceutical companies’ reverse payment patent settlements are among the most hotly debated and fastest developing areas of antitrust law. Most recently, the FTC for the first time challenged such a settlement due to an agreement not to market an authorized generic. The program will bring together experts with agency enforcement, private practice and academic backgrounds to discuss this and other recent developments in this area from their diverse perspectives.
Winston & Strawn
1700 K St., N.W.
If you plan to appear in person contact: Elizabeth Birk (firstname.lastname@example.org) (202) 282-5207.
For this and all upcoming events visit https://shop.americanbar.org/ebus/abaeventscalendar.aspx.
FREE: Antitrust Section Members, Government, Non-profit Employees, Students
Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25. For this and all upcoming events visit http://ambar.org/atevents.
The ABA is not seeking CLE credit for this program.
Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.